Goodbay

  In 2024, the spotlight will shine brightly on HMPV (Human Metapneumovirus) in the world of healthcare and respiratory infections. Although the HMPV was first identified in 2001, no cases of HMPV have been reported yet. Closely related to respiratory syncytial virus (RSV), the virus has become a topic of interest due to its impact on vulnerable populations such as children, the elderly and the immunocompromised because of the disruption of the immune system H.M.P.V. By 2024, it was recognized as one of the leading causes of respiratory diseases worldwide, often manifesting symptoms such as fever, cough, nasal congestion and wheezing Despite this prevalence, many people still own HMPV. Health professionals are working hard to raise awareness of HMPV to encourage early diagnosis and treatment. Prevention is key, as hygiene practices such as washing hands regularly, wearing masks in crowded places, and avoiding close contact with those who are sick are effective fighting strategies a...